SYROS PHARMACEUTICALS, INC. Severance Costs
SYROS PHARMACEUTICALS, INC. reported Severance Costs of $2.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. severance costs for the quarter ending 2023-12-31 was $0.00.
- SYROS PHARMACEUTICALS, INC. severance costs for fiscal 2023 was $2.00M.
| Period end | Severance Costs 3 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.00M 10-K · filed 2024-03-27 | |
| 2023-09-30 | $2.00M 10-Q · filed 2024-10-31 |